Targeting bacterial secretion systems: benefits of disarmament in the microcosm.
about
The Structure and Specificity of the Type III Secretion System Effector NleC Suggest a DNA Mimicry Mechanism of Substrate RecognitionThe Role of Bacterial Secretion Systems in the Virulence of Gram-Negative Airway Pathogens Associated with Cystic FibrosisCharacterization of transcription factors that regulate the type IV secretion system and riboflavin biosynthesis in Wolbachia of Brugia malayiIdentification and characterization of potential therapeutic candidates in emerging human pathogen Mycobacterium abscessus: a novel hierarchical in silico approachFunctional annotation of conserved hypothetical proteins from Haemophilus influenzae Rd KW20Biological diversity of prokaryotic type IV secretion systems.Structural analysis of a specialized type III secretion system peptidoglycan-cleaving enzyme.An in vivo high-throughput screening approach targeting the type IV secretion system component VirB8 identified inhibitors of Brucella abortus 2308 proliferation.Acinetobacter baumannii: emergence of a successful pathogenSynthesis and structure-activity relationships of novel phenoxyacetamide inhibitors of the Pseudomonas aeruginosa type III secretion system (T3SS).Andrographolide inhibits intracellular Chlamydia trachomatis multiplication and reduces secretion of proinflammatory mediators produced by human epithelial cells.VirB8: a conserved type IV secretion system assembly factor and drug target.Synthesis of and evaluation of lipid A modification by 4-substituted 4-deoxy arabinose analogs as potential inhibitors of bacterial polymyxin resistance.Secretion of TcpF by the Vibrio cholerae toxin-coregulated pilus biogenesis apparatus requires an N-terminal determinant.Use of animal models in the development of human vaccines.Bacterial type IV secretion systems in human disease.Potential of known and short prokaryotic protein motifs as a basis for novel peptide-based antibacterial therapeutics: a computational survey.In silico functional elucidation of uncharacterized proteins of Chlamydia abortus strain LLG.Antibacterials from the sea.Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function.Enterococcus faecalis PcfC, a spatially localized substrate receptor for type IV secretion of the pCF10 transfer intermediate.Lytic transglycosylases: concinnity in concision of the bacterial cell wall.Towards New Drug Targets? Function Prediction of Putative Proteins of Neisseria meningitidis MC58 and Their Virulence Characterization.Identification of functional candidates amongst hypothetical proteins of Mycobacterium leprae Br4923, a causative agent of leprosy.Substituted 2-imino-5-arylidenethiazolidin-4-one inhibitors of bacterial type III secretion.Dissection of a type VI secretion system in Edwardsiella tarda.Acinetobacter: an emerging pathogen with a versatile secretome.Structure-based function analysis of putative conserved proteins with isomerase activity from Haemophilus influenzae.
P2860
Q27684732-D9A31D56-B14C-439E-8221-07AE560DE4D8Q28068051-02FF7114-47D5-41EA-B41C-4FF3857A6EE9Q28484257-56A181BC-624B-4531-A0C1-5FBB1556D729Q28488335-078EAA18-1FBC-4226-8D35-1B67BA173611Q28538178-FE55A8AD-4260-4265-926E-AD1564A7318FQ30927042-BC2DB22A-A483-49D4-A1FC-2AFF7CC8C009Q34462580-054A8AED-BB76-4CA5-82FC-63DF5E6872DFQ34739706-F6B4621B-485D-4149-997D-38D6600BC50DQ34795807-F7D49E0A-E29F-4958-8B46-8BCFC3A7BB1EQ35118409-EB217F1E-9986-4932-9222-D22FC45CAFC3Q35975515-684447E3-9130-488E-B9FF-0E11680AB64EQ36704506-BACD539B-F647-4B83-BD89-9F3CD19DB04CQ36837982-0A3BE6D8-8C24-43A3-8E29-1EC7D741368FQ36969526-7144B2E3-AC00-49F8-B7D8-BB89965EBEADQ37015991-684816C3-8F84-4912-A791-94F6E043867DQ37445142-5D99DCFD-B4D4-4FD9-B6BA-E5EB083C9D0CQ37498015-DE4E3D2C-B2BE-4186-8425-18DFE348947CQ37701432-71BC2A8F-9497-421B-AFF5-A58DE3585B16Q37789260-D38F0A5C-ECA3-4D42-92D6-40B6E97FD3CBQ38006509-D525C74D-1235-4F25-BE6A-A403AE22C7ADQ38608495-3B71F020-F9B3-40FF-822B-D3DD6214C59DQ38667595-EDE6B00A-30E0-46E8-B80B-979062013854Q41160003-F74BFB5B-6149-40F7-B3D9-F9C0CBA377B1Q41221996-4C3FFFEC-F34B-4219-9F3C-E88595649024Q43177321-5C3B5FAA-EDF2-49A4-B1A2-AAC7FEF199EAQ48076617-3D1CDFB6-6708-4139-AE51-43A51AEF3A7FQ52646120-857BD841-6F86-40C3-8A31-51BD0BA09958Q55287635-5A31E4EB-488A-4B1D-8649-435399DB4400
P2860
Targeting bacterial secretion systems: benefits of disarmament in the microcosm.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Targeting bacterial secretion systems: benefits of disarmament in the microcosm.
@ast
Targeting bacterial secretion systems: benefits of disarmament in the microcosm.
@en
type
label
Targeting bacterial secretion systems: benefits of disarmament in the microcosm.
@ast
Targeting bacterial secretion systems: benefits of disarmament in the microcosm.
@en
prefLabel
Targeting bacterial secretion systems: benefits of disarmament in the microcosm.
@ast
Targeting bacterial secretion systems: benefits of disarmament in the microcosm.
@en
P1476
Targeting bacterial secretion systems: benefits of disarmament in the microcosm
@en
P2093
Christian Baron
P356
10.2174/187152607780090685
P577
2007-03-01T00:00:00Z